全文获取类型
收费全文 | 3089篇 |
免费 | 134篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 236篇 |
妇产科学 | 31篇 |
基础医学 | 326篇 |
口腔科学 | 97篇 |
临床医学 | 138篇 |
内科学 | 714篇 |
皮肤病学 | 22篇 |
神经病学 | 275篇 |
特种医学 | 48篇 |
外科学 | 343篇 |
综合类 | 101篇 |
预防医学 | 153篇 |
眼科学 | 166篇 |
药学 | 300篇 |
中国医学 | 16篇 |
肿瘤学 | 210篇 |
出版年
2023年 | 18篇 |
2022年 | 45篇 |
2021年 | 101篇 |
2020年 | 55篇 |
2019年 | 63篇 |
2018年 | 87篇 |
2017年 | 43篇 |
2016年 | 61篇 |
2015年 | 61篇 |
2014年 | 90篇 |
2013年 | 98篇 |
2012年 | 173篇 |
2011年 | 182篇 |
2010年 | 99篇 |
2009年 | 79篇 |
2008年 | 140篇 |
2007年 | 134篇 |
2006年 | 150篇 |
2005年 | 108篇 |
2004年 | 85篇 |
2003年 | 97篇 |
2002年 | 88篇 |
2001年 | 57篇 |
2000年 | 66篇 |
1999年 | 73篇 |
1998年 | 31篇 |
1997年 | 23篇 |
1996年 | 23篇 |
1994年 | 17篇 |
1993年 | 19篇 |
1992年 | 62篇 |
1991年 | 78篇 |
1990年 | 37篇 |
1989年 | 69篇 |
1988年 | 56篇 |
1987年 | 60篇 |
1986年 | 60篇 |
1985年 | 36篇 |
1984年 | 25篇 |
1983年 | 18篇 |
1979年 | 33篇 |
1978年 | 16篇 |
1977年 | 24篇 |
1975年 | 19篇 |
1974年 | 39篇 |
1973年 | 35篇 |
1972年 | 26篇 |
1971年 | 22篇 |
1969年 | 17篇 |
1966年 | 20篇 |
排序方式: 共有3234条查询结果,搜索用时 11 毫秒
41.
42.
Nidhi Tandon Surbhi Sidana S. Vincent Rajkumar Angela Dispenzieri Morie A. Gertz Martha Q. Lacy 《Amyloid》2017,24(3):183-188
We analysed factors predicting early treatment failure (ETF), after first-line therapy for light-chain amyloidosis (AL). AL amyloidosis patients seen at Mayo Clinic within 90?days of diagnosis, from 2006 to 2015, excluding those who died within 3 months of initial therapy, were analysed retrospectively. ETF was defined as progression requiring treatment change or death within 12 (ETF12) or 24 (ETF24) months of first-line treatment. Non-ETF included those with a follow-up of more than 12 or 24 months who had progression beyond 12 or 24 months. A total of 724 patients met the study criteria; 244 (33.7%) had ETF12 and 388 (53.6%) had ETF24. Patients with ETF12 were older (64.1 vs. 62.2?years) with higher prevalence of cardiac (81 vs. 64.1%) and multi-organ involvement (67.2 vs. 45.4%) and higher proportion of patients with t(11; 14) (58.5 vs. 44.3%) or in higher Mayo 2012 stage (58.5 vs. 41.1%).The median follow-up was 5.4?years from start of initial therapy. In multivariate analysis, presence of t(11; 14) and non-incorporation of autologous transplant in initial therapy are significant predictors of ETF12 (p?=?.01and p?=?.003) and ETF24 (p?=?.0001 and p?=?.005) while Mayo stage is predictive of ETF24 (p?=?.002), but not ETF12. 相似文献
43.
44.
Incremental benefit of three‐dimensional transthoracic echocardiography in the assessment of left atrial appendage aneurysm leading to severe extrinsic compression of a coronary artery 下载免费PDF全文
Rohit Tandon MD Mohammed J. Arisha MD Navin C. Nanda MD Sooraj Kumar MD Gurpreet S. Wander MD Swetha Srialluri MD Hassan Kamel MD Ahmed Y. Salama MBChB 《Echocardiography (Mount Kisco, N.Y.)》2018,35(5):685-691
Left atrial appendage aneurysm (LAA AN) is a rare disease entity, which can be congenital or acquired in nature. We report an adult patient with LAA AN presenting with anginal chest pain in whom live/real time three‐dimensional transthoracic echocardiography (3DTTE) provided incremental value over the two‐dimensional (2D) technique in providing a more comprehensive assessment of the lesion. A literature review of the salient features of LAA AN is also provided in a tabular form. 相似文献
45.
46.
47.
Rathor Laxmi Pant Aakanksha Nagar Abhishek Tandon Sudeep Trivedi Shalini Pandey Rakesh 《Proceedings of the National Academy of Sciences, India. Section B.》2017,87(4):1355-1362
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - The use of herbs in the form of dietary supplements and medicine is fascinating the world, owing to their... 相似文献
48.
49.
Thuluvath PJ Maheshwari A Jagannath S Arepally A 《Digestive diseases and sciences》2005,50(2):407-410
Primary prophylaxis with nonselective -blockers in high-risk subjects has been shown to be effective in reducing both esophageal variceal bleeding and mortality. Recently it has been suggested that band ligation may be a better option for primary prophylaxis. We compared nonselective -blockers with band ligation in patients with large varices (F2, F3) and elevated hepatic venous wedge pressure gradient (HVWPG, 12 mm Hg). All patients were prospectively followed for variceal bleeding, mortality, and treatment-related complications. Based on previous published studies, we estimated that 90 patients in each arm would be required to show a difference in bleeding rate. The study was prematurely terminated when we realized that our estimated sample size was inadequate to show a difference based on the observed bleeding rate. At the time of termination, 31 patients (Child A, 11; B, 14; C, 6), with a mean HVWPG of 19 ± 9.1 mm Hg, were randomized to either band ligation (group A; n = 16) or -blockers (group B; n = 15). Baseline demographics of both groups were similar and the mean follow-up period was 27.4 ± 12.9 months. During the follow-up, two patients in group A and one patient in group B had bleeding. Nine patients (29%; group A, six; group B, three; P = ns) died due to non-bleeding-related causes and five (16%) patients (group A, three; group B, two) underwent liver transplantation. Treatment-related complication were minimal in both groups. Despite the selection of high-risk patients, the observed bleeding rate was much lower than anticipated. Based on our observed bleeding rates, 424 patients would be required in each arm to show a difference between band ligation and -blocker therapy. 相似文献
50.
S. Dasarathy S. C. Misra S. K. Acharya M. Irshad Y. K. Joshi P. Venugopal B. N. Tandon 《Liver international》1992,12(3):116-120
ABSTRACT— We studied the risk of post-transfusion hepatitis (PTH) in recipients of blood collected from voluntary donors screened for HBsAg. Two hundred and fifty patients without any previous history of liver disease or transfusion were followed up for 12 months subsequent to cardiac surgery. Thirty-five of them had closed-heart surgery without receiving transfusion and served as controls. The remaining 215 patients received single-point transfusions (mean 4 ± 2.4 units). None of the controls and 15 (6.9%) blood recipients developed PTH. Three (20%) patients had hepatitis-B-virus-induced hepatitis while the remainder (80%) had non A, non B (NANB) hepatitis. The number of units of blood transfused and surrogate markers for development of PTH (donor alanine aminotransferase, anti-HBc and anti-HBs antibody) were not associated with the occurrence of PTH (p>0.05). Nine (60%) of the 15 patients developing PTH were asymptomatic. All the patients recovered from the PTH, except one who died of fulminant hepatitis. At the end of 1 year of follow-up, none of the patients had evidence of chronic hepatitis. Only three (25%) of the patients with NANB-PTH developed anti-hepatitis C virus (HCV) antibody during the follow-up. We conclude that the incidence of PTH in India is similar to other parts of the world and NANB virus was the major cause of the PTH. The absence of chronicity and lack of seroconversion to anti-HCV antibody in the majority of the patients after 1 year of follow-up may suggest the possibility of a NANB virus other than HCV as the major cause of PTH in India. 相似文献